Genetic Basis of Immunodeficiency
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00055172|
Recruitment Status : Recruiting
First Posted : February 20, 2003
Last Update Posted : March 29, 2018
This study will examine the role of hereditary factors in different forms of severe combined immunodeficiency (SCID).
Patients with immunodeficiencies may be eligible for this study. Candidates include:
- Patients with diminished numbers of T cells or NK cells or both, or
- Patients with normal T cell and NK cell numbers but diminished T cell, B cell, or NK cell function.
Relatives of patients will also be studied.
Participants will have blood samples collected for genetic analysis in studies related to SCID at the National Institutes of Health and other institutions.
|Condition or disease|
|Severe Combined Immunodeficiency|
|Study Type :||Observational|
|Estimated Enrollment :||99999999 participants|
|Official Title:||The Determination of Genetic Basis Of Immunodeficiency|
|Study Start Date :||February 19, 2003|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00055172
|Contact: Warren J Leonard, M.D.||(301) firstname.lastname@example.org|
|United States, Maryland|
|National Institutes of Health Clinical Center, 9000 Rockville Pike||Recruiting|
|Bethesda, Maryland, United States, 20892|
|Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR) 800-411-1222 ext TTY8664111010 email@example.com|
|Universidad de Immunologia||Recruiting|
|Principal Investigator:||Warren J Leonard, M.D.||National Heart, Lung, and Blood Institute (NHLBI)|